LysoX

Zhejiang Rongmei Biomedical Technology Co., Ltd. is a startup dedicated to tackling neurodegenerative diseases and other lysosomal function deficiency diseases, aiming to become a global leader in novel lysosomal ion channel and transporter-targeted drugs. Founded in 2024 in Hangzhou Future Science and Technology City, the company has received recognition from multiple domestic investment institutions and policy support from Zhejiang Province and Yuhang District government. Rongmei Bio's R&D center is located in Health Valley, covering approximately 1,200 square meters, focusing on new drug development and early preclinical sample research.